# Forefront Analytics, LLC

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1696802. Source: https://holderbook.com/funds/1696802-forefront-analytics-llc/

- Reported value: $92.0M
- Positions: 37
- Weight of the ten largest: 82.7%
- Filed: 2026-08-13

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| VANGUARD INTL EQUITY INDEX F | [VWO](https://holderbook.com/stocks/VWO/) | $10.8M | 180,376 | 11.7% | 31 |
| ISHARES TR | [ESGD](https://holderbook.com/stocks/ESGD/) | $10.7M | 104,247 | 11.6% | 5 |
| ISHARES INC | [ESGE](https://holderbook.com/stocks/ESGE/) | $10.5M | 192,398 | 11.4% | 5 |
| ISHARES TR | [HDV](https://holderbook.com/stocks/HDV/) | $9.4M | 342,756 | 10.2% | 31 |
| ISHARES TR | [MTUM](https://holderbook.com/stocks/MTUM/) | $8.4M | 24,434 | 9.1% | 31 |
| NUSHARES ETF TR | [NULV](https://holderbook.com/stocks/NULV/) | $7.0M | 140,912 | 7.7% | 10 |
| DBX ETF TR | [DBEF](https://holderbook.com/stocks/DBEF/) | $6.9M | 126,734 | 7.5% | 31 |
| FLEXSHARES TR | [ESGG](https://holderbook.com/stocks/ESGG/) | $5.1M | 21,669 | 5.5% | 4 |
| NVIDIA CORPORATION | [NVDA](https://holderbook.com/stocks/NVDA/) | $3.9M | 19,532 | 4.2% | 26 |
| VANGUARD TAX-MANAGED FDS | [VEA](https://holderbook.com/stocks/VEA/) | $3.4M | 47,559 | 3.7% | 31 |
| ISHARES TR | [IVV](https://holderbook.com/stocks/IVV/) | $3.3M | 4,450 | 3.6% | 31 |
| ISHARES INC | [HEEM](https://holderbook.com/stocks/HEEM/) | $2.6M | 58,203 | 2.8% | 31 |
| JPMORGAN CHASE & CO | [JPM](https://holderbook.com/stocks/JPM/) | $1.6M | 4,997 | 1.8% | 31 |
| DEERE & CO | [DE](https://holderbook.com/stocks/DE/) | $743.2K | 1,172 | 0.8% | 24 |
| UNITEDHEALTH GROUP INC | [UNH](https://holderbook.com/stocks/UNH/) | $585.8K | 1,409 | 0.6% | 16 |
| INCYTE CORP | [INCY](https://holderbook.com/stocks/INCY/) | $577.1K | 5,091 | 0.6% | 15 |
| EDWARDS LIFESCIENCES CORP | [EW](https://holderbook.com/stocks/EW/) | $557.1K | 6,158 | 0.6% | 8 |
| PROSHARES TR | [SSO](https://holderbook.com/stocks/SSO/) | $551.2K | 8,180 | 0.6% | 7 |
| PROSHARES TR | [UWM](https://holderbook.com/stocks/UWM/) | $537.7K | 7,997 | 0.6% | 31 |
| ABBOTT LABORATORIES | [ABT](https://holderbook.com/stocks/ABT/) | $514.1K | 5,665 | 0.6% | 5 |
| WISDOMTREE TR | [EES](https://holderbook.com/stocks/EES/) | $475.9K | 7,020 | 0.5% | 31 |
| PFIZER INC | [PFE](https://holderbook.com/stocks/PFE/) | $438.5K | 18,210 | 0.5% | 19 |
| MEDTRONIC PLC | [MDT](https://holderbook.com/stocks/MDT/) | $416.1K | 5,319 | 0.5% | 8 |
| DANAHER CORP DEL | [DHR](https://holderbook.com/stocks/DHR/) | $388.5K | 2,040 | 0.4% | 4 |
| THERMO FISHER SCIENTIFIC INC | [TMO](https://holderbook.com/stocks/TMO/) | $335.6K | 669 | 0.4% | 3 |
| BLUE OWL TECHNOLOGY FIN CORP | [OTF](https://holderbook.com/stocks/OTF/) | $306.9K | 29,654 | 0.3% | 2 |
| LEGEND BIOTECH CORP | [LEGN](https://holderbook.com/stocks/LEGN/) | $305.2K | 10,568 | 0.3% | 2 |
| PHILIP MORRIS INTL INC | [PM](https://holderbook.com/stocks/PM/) | $264.6K | 1,463 | 0.3% | 6 |
| REGENERON PHARMACEUTICALS | [REGN](https://holderbook.com/stocks/REGN/) | $258.8K | 415 | 0.3% | 5 |
| SCHWAB STRATEGIC TR | [SCHD](https://holderbook.com/stocks/SCHD/) | $243.4K | 7,676 | 0.3% | 2 |
| VANGUARD INDEX FDS | [VTV](https://holderbook.com/stocks/VTV/) | $236.3K | 1,084 | 0.3% | 31 |
| ZURA BIO LTD | [ZURA](https://holderbook.com/stocks/ZURA/) | $159.1K | 26,968 | 0.2% | 12 |
| GERON CORP | [GERN](https://holderbook.com/stocks/GERN/) | $113.6K | 88,779 | 0.1% | 24 |
| CYTOMX THERAPEUTICS INC | [CTMX](https://holderbook.com/stocks/CTMX/) | $93.9K | 25,033 | 0.1% | 20 |
| BICYCLE THERAPEUTICS PLC | [BCYC](https://holderbook.com/stocks/BCYC/) | $92.5K | 21,822 | 0.1% | 3 |
| NKARTA INC | [NKTX](https://holderbook.com/stocks/NKTX/) | $81.9K | 28,955 | 0.1% | 9 |
| ANNEXON INC | [ANNX](https://holderbook.com/stocks/ANNX/) | $81.3K | 14,240 | 0.1% | 18 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +13.2% | +14.8% | -1.7% | 100% |
| Q1 2026 | +1.0% | -4.6% | +5.6% | 100% |
| Q4 2025 | +1.6% | +2.4% | -0.8% | 100% |
| Q3 2025 | +6.7% | +7.8% | -1.1% | 100% |
| Q2 2025 | +7.5% | +10.5% | -2.9% | 100% |
| Q1 2025 | +1.8% | -4.6% | +6.4% | 100% |
| Q4 2024 | -4.1% | +2.1% | -6.2% | 100% |
| Q3 2024 | +6.4% | +5.4% | +1.0% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $92.0M | 37 |
| Q1 2026 | $110.0M | 39 |
| Q4 2025 | $113.3M | 43 |
| Q3 2025 | $103.8M | 43 |
| Q2 2025 | $89.5M | 43 |
| Q1 2025 | $86.9M | 45 |
| Q4 2024 | $215.0M | 64 |
| Q3 2024 | $212.0M | 67 |
| Q2 2024 | $208.9M | 68 |
| Q1 2024 | $206.2M | 67 |
| Q4 2023 | $202.6M | 67 |
| Q3 2023 | $176.3M | 67 |